Protein and energy: Recommended intake and nutrient supplementation in chronic dialysis patients

被引:27
作者
Ikizler, TA [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Div Nephrol, Dept Med, Nashville, TN 37232 USA
关键词
D O I
10.1111/j.0894-0959.2004.17608.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Nutritional status is an important predictor of clinical outcome in end-stage renal disease (ESRD) patients, especially in patients on chronic hemodialysis. Uremic malnutrition is strongly associated with increased risk of death and hospitalization events in this patient population, and decreased muscle mass is the most significant predictor of these outcomes. Several factors that influence protein metabolism predispose chronic hemodialysis patients to increased catabolism and loss of lean body mass. The available evidence suggests that low protein and energy intake associated with advanced uremia along with catabolic consequences of dialytic therapies can lead to the development of uremic malnutrition. Recent studies show that the hemodialysis procedure induces a net protein catabolic state at the whole-body level as well as skeletal muscle. There is evidence to suggest that these undesirable effects are due to decreased protein synthesis and increased proteolysis. Provision of nutrients, either in the form of intradialytic parenteral nutrition or oral feeding during hemodialysis, can adequately compensate for the catabolic effects of the hemodialysis procedure. While the mechanisms of these effects are not studied in detail, changes in extracellular amino acid concentrations, along with certain anabolic hormones such as insulin, are important mediators of these actions.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 49 条
[1]  
Anderstam B, 1996, J AM SOC NEPHROL, V7, P2453
[2]  
BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329
[3]  
BERGSTROM J, 1989, ADV EXP MED BIOL, V260, P1
[4]   NITROGEN-BALANCE DURING INTERMITTENT DIALYSIS THERAPY OF UREMIA [J].
BORAH, MF ;
SCHOENFELD, PY ;
GOTCH, FA ;
SARGENT, JA ;
WOLFSON, M ;
HUMPHREYS, MH .
KIDNEY INTERNATIONAL, 1978, 14 (05) :491-500
[5]   Therapeutic effects of oral nutritional supplementation during hemodialysis [J].
Caglar, K ;
Fedje, L ;
Dimmitt, R ;
Hakim, RM ;
Shyr, Y ;
Ikizler, TA .
KIDNEY INTERNATIONAL, 2002, 62 (03) :1054-1059
[6]   PERDIALYTIC PARENTERAL-NUTRITION WITH LIPIDS AND AMINO-ACIDS IN MALNOURISHED HEMODIALYSIS-PATIENTS [J].
CANO, N ;
LABASTIECOEYREHOURQ, J ;
LACOMBE, P ;
STROUMZA, P ;
DICOSTANZODUFETEL, J ;
DURBEC, JP ;
COUDRAYLUCAS, C ;
CYNOBER, L .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 52 (04) :726-730
[7]   THE ASSOCIATION OF INTRADIALYTIC PARENTERAL-NUTRITION ADMINISTRATION WITH SURVIVAL IN HEMODIALYSIS-PATIENTS [J].
CHERTOW, GM ;
LING, J ;
LEW, NL ;
LAZARUS, JM ;
LOWRIE, EG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (06) :912-920
[8]   CANADIAN HEMODIALYSIS MORBIDITY STUDY [J].
CHURCHILL, DN ;
TAYLOR, DW ;
COOK, RJ ;
LAPLANTE, P ;
BARRE, P ;
CARTIER, P ;
FAY, WP ;
GOLDSTEIN, MB ;
JINDAL, K ;
MANDIN, H ;
MCKENZIE, JK ;
MUIRHEAD, N ;
PARFREY, PS ;
POSEN, GA ;
SLAUGHTER, D ;
ULAN, RA ;
WERB, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) :214-234
[9]   UREA INDEX AND OTHER PREDICTORS OF HEMODIALYSIS PATIENT SURVIVAL [J].
COLLINS, AJ ;
MA, JZ ;
UMEN, A ;
KESHAVIAH, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :272-282
[10]  
Cranford W, 1998, Nephrol News Issues, V12, P33